MoonLake Immunotherapeutics
MLTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821586
In the last 90 days, MoonLake Immunotherapeutics insiders filed 0 open-market purchases and 6 sales; 172 institutions reported holding it in 13F filings for Q2 2026, worth $1.43B in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in MoonLake Immunotherapeutics as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 130
- −4 vs. Q1 2025
- Shares held
- 58.8M
- −1.12M (−1.9%) vs. Q1 2025
- Total value
- $2.77B
- +$434.1M (+18.6%) vs. Q1 2025
- New holders
- 23
- 37 more added
- Sold out
- 27
- 52 more reduced
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MLTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 172 | $1.43B |
| Q1 2026 | 147 | $1.17B |
| Q4 2025 | 130 | $742.9M |
| Q3 2025 | 134 | $269.7M |
| Q2 2025 | 130 | $2.77B |
| Q1 2025 | 136 | $2.34B |
| Q4 2024 | 116 | $3.43B |
| Q3 2024 | 109 | $3.14B |
| Q2 2024 | 111 | $2.67B |
| Q1 2024 | 114 | $2.99B |
| Q4 2023 | 125 | $3.53B |
| Q3 2023 | 118 | $3.21B |
| Q2 2023 | 83 | $2.86B |
| Q1 2023 | 43 | $843.2M |
| Q4 2022 | 33 | $396.4M |
| Q3 2022 | 24 | $291.4M |
| Q2 2022 | 23 | $190.1M |
| Q1 2022 | 27 | $123.4M |
| Q4 2021 | 45 | $112.8M |
| Q3 2021 | 43 | $111.1M |
| Q2 2021 | 46 | $115.8M |
| Q1 2021 | 42 | $108.9M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding MoonLake Immunotherapeutics; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 186,568 | $8.81M | 0.02% | +186,568 | New |
| Logos Global Management LP | 200,000 | $9.44M | 1.26% | −150,000−42.9% | Reduced |
| Integral Health Asset Management, LLC | 200,000 | $9.44M | 0.88% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 200,321 | $9.46M | 0.00% | −1,200−0.6% | Reduced |
| Voya Investment Management LLC | 246,114 | $11.6M | 0.01% | −146,810−37.4% | Reduced |
| Polar Capital Holdings Plc | 247,500 | $11.7M | 0.06% | −852,500−77.5% | Reduced |
| 5AM Venture Management, LLC | 282,313 | $13.3M | 5.12% | 00.0% | Unchanged |
| Saturn V Capital Management LLC | 290,784 | $13.7M | 5.56% | −53,065−15.4% | Reduced |
| Fred Alger Management, LLC | 295,623 | $14.0M | 0.06% | −347,258−54.0% | Reduced |
| Woodline Partners LP | 310,602 | $14.7M | 0.08% | +14,454+4.9% | Added |
| MPM Oncology Impact Management LP | 313,571 | $14.8M | 2.56% | −2,478−0.8% | Reduced |
| BlackRock, Inc. | 327,342 | $15.5M | 0.00% | +41,133+14.4% | Added |
| Balyasny Asset Management LLC | 423,170 | $20.0M | 0.05% | +344,335+436.8% | Added |
| Siren, L.L.C. | 508,267 | $24.0M | 1.24% | +508,267 | New |
| Marshall Wace, LLP | 529,211 | $25.0M | 0.03% | −111,706−17.4% | Reduced |
| Vestal Point Capital, LP | 550,000 | $26.0M | 1.37% | +350,000+175.0% | Added |
| Hood River Capital Management LLC | 675,445 | $31.9M | 0.45% | +12,462+1.9% | Added |
| RTW Investments, LP | 741,090 | $35.0M | 0.50% | +741,090 | New |
| Nuveen, LLC | 791,555 | $37.4M | 0.01% | +118,212+17.6% | Added |
| Paradigm Biocapital Advisors LP | 878,323 | $41.5M | 1.77% | +250,900+40.0% | Added |
| Alliancebernstein L.P. | 1,138,022 | $53.7M | 0.02% | +171,932+17.8% | Added |
| Federated Hermes, Inc. | 1,248,573 | $58.9M | 0.11% | −20,778−1.6% | Reduced |
| Westfield Capital Management Co LP | 1,259,376 | $59.4M | 0.25% | −175,394−12.2% | Reduced |
| Goldman Sachs Group Inc | 1,275,569 | $60.2M | 0.01% | −17,039−1.3% | Reduced |
| Citadel Advisors LLC | 1,674,041 | $79.0M | 0.07% | +195,406+13.2% | Added |
| Price T Rowe Associates Inc | 2,613,233 | $123.3M | 0.01% | −360,597−12.1% | Reduced |
| Avoro Capital Advisors LLC | 4,150,000 | $195.9M | 3.43% | +1,379,900+49.8% | Added |
| FMR LLC | 5,730,549 | $270.5M | 0.02% | −596,465−9.4% | Reduced |
| Cormorant Asset Management, LP | 8,494,151 | $400.9M | 29.86% | 00.0% | Unchanged |
| BVF Inc | 19,751,284 | $932.3M | 33.31% | 00.0% | Unchanged |
| Camber Capital Management LP | 0 | $0 | 0.00% | −441,000−100.0% | Sold out |
| Finepoint Capital LP | 0 | $0 | 0.00% | −435,785−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −344,320−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −191,500−100.0% | Sold out |
| Holocene Advisors, LP | 0 | $0 | 0.00% | −188,989−100.0% | Sold out |
| First Turn Management, LLC | 0 | $0 | 0.00% | −179,196−100.0% | Sold out |
| Nicholas Investment Partners, LP | 0 | $0 | 0.00% | −46,933−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −35,638−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −27,489−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −26,764−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −25,400−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Wexford Capital LP | 0 | $0 | 0.00% | −21,500−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −14,664−100.0% | Sold out |
| BIT Capital GmbH | 0 | $0 | 0.00% | −14,610−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −10,669−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −9,900−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −9,510−100.0% | Sold out |
| Caxton Associates LLP | 0 | $0 | 0.00% | −8,880−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −8,495−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −6,992−100.0% | Sold out |
| Legato Capital Management LLC | 0 | $0 | 0.00% | −6,142−100.0% | Sold out |
| Wealth Preservation Advisors, LLC | 0 | $0 | 0.00% | −120−100.0% | Sold out |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 0 | $0 | 0.00% | −85−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Creative Financial Designs Inc | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| TD Private Client Wealth LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Glenmede Trust Co NA | – | – | – | – | Not filed |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |